Your browser doesn't support javascript.
loading
Artificial Intelligence-Enabled Quantitative Coronary Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome.
Koo, Bon-Kwon; Yang, Seokhun; Jung, Jae Wook; Zhang, Jinlong; Lee, Keehwan; Hwang, Doyeon; Lee, Kyu-Sun; Doh, Joon-Hyung; Nam, Chang-Wook; Kim, Tae Hyun; Shin, Eun-Seok; Chun, Eun Ju; Choi, Su-Yeon; Kim, Hyun Kuk; Hong, Young Joon; Park, Hun-Jun; Kim, Song-Yi; Husic, Mirza; Lambrechtsen, Jess; Jensen, Jesper M; Nørgaard, Bjarne L; Andreini, Daniele; Maurovich-Horvat, Pal; Merkely, Bela; Penicka, Martin; de Bruyne, Bernard; Ihdayhid, Abdul; Ko, Brian; Tzimas, Georgios; Leipsic, Jonathon; Sanz, Javier; Rabbat, Mark G; Katchi, Farhan; Shah, Moneal; Tanaka, Nobuhiro; Nakazato, Ryo; Asano, Taku; Terashima, Mitsuyasu; Takashima, Hiroaki; Amano, Tetsuya; Sobue, Yoshihiro; Matsuo, Hitoshi; Otake, Hiromasa; Kubo, Takashi; Takahata, Masahiro; Akasaka, Takashi; Kido, Teruhito; Mochizuki, Teruhito; Yokoi, Hiroyoshi; Okonogi, Taichi.
Afiliação
  • Koo BK; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul National University of College of Medicine, Seoul, South Korea. Electronic address: bkkoo@snu.ac.kr.
  • Yang S; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul National University of College of Medicine, Seoul, South Korea.
  • Jung JW; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul National University of College of Medicine, Seoul, South Korea.
  • Zhang J; Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Lee K; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul National University of College of Medicine, Seoul, South Korea.
  • Hwang D; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul National University of College of Medicine, Seoul, South Korea.
  • Lee KS; Department of Cardiology, Eulji University Medical Center, Daejeon, South Korea.
  • Doh JH; Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, South Korea.
  • Nam CW; Department of Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea.
  • Kim TH; Department of Cardiology, Ulsan Medical Center, Ulsan, South Korea.
  • Shin ES; Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Chun EJ; Department of Radiology, Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Choi SY; Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea.
  • Kim HK; Department of Internal Medicine and Cardiovascular Center, Chosun University Hospital, University of Chosun College of Medicine, Gwangju, South Korea.
  • Hong YJ; Department of Cardiology, Chonnam National University Hospital, Gwangju, South Korea.
  • Park HJ; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
  • Kim SY; Division of Cardiology, Department of Internal Medicine, Jeju National University Hospital, Jeju, South Korea.
  • Husic M; Department of Cardiology, Odense University Hospital, Svendborg, Denmark.
  • Lambrechtsen J; Department of Cardiology, Odense University Hospital, Svendborg, Denmark.
  • Jensen JM; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • Nørgaard BL; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • Andreini D; Centro Cardiologico Manzano, Istituti di Ricovero e Cura a Carattere Scientifico Milan, Italy; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
  • Maurovich-Horvat P; Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary.
  • Merkely B; The Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Penicka M; Cardiovascular Center Aalst, Onze Lieve Vrouwziekenhuis-Clinic, Aalst, Belgium.
  • de Bruyne B; Cardiovascular Center Aalst, Onze Lieve Vrouwziekenhuis-Clinic, Aalst, Belgium.
  • Ihdayhid A; Monash Cardiovascular Research Centre, Monash University and Monash Heart, Monash Health, Clayton, Victoria, Australia.
  • Ko B; Monash Cardiovascular Research Centre, Monash University and Monash Heart, Monash Health, Clayton, Victoria, Australia.
  • Tzimas G; Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Leipsic J; Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Sanz J; Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Rabbat MG; Division of Cardiology, Loyola University Chicago, Chicago, Illinois, USA.
  • Katchi F; Department of Cardiology, Washington University School of Medicine in St. Louis, Missouri, USA.
  • Shah M; Department of Cardiology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
  • Tanaka N; Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
  • Nakazato R; Cardiovascular Center, St Luke's International Hospital, Tokyo, Japan.
  • Asano T; Cardiovascular Center, St Luke's International Hospital, Tokyo, Japan.
  • Terashima M; Department of Cardiovascular Medicine, Toyohashi Heart Center, Aichi, Japan.
  • Takashima H; Department of Cardiology, Aichi Medical University, Nagakute, Japan.
  • Amano T; Department of Cardiology, Aichi Medical University, Nagakute, Japan.
  • Sobue Y; Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.
  • Matsuo H; Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.
  • Otake H; Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Kubo T; Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
  • Takahata M; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
  • Akasaka T; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
  • Kido T; Department of Radiology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Mochizuki T; Department of Radiology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Yokoi H; Cardiovascular Center, Fukuoka Sanno Hospital, Fukuoka, Japan.
  • Okonogi T; Cardiovascular Center, Shin-Koga Hospital, Kurume, Japan.
Article em En | MEDLINE | ID: mdl-38752951
ABSTRACT

BACKGROUND:

A lesion-level risk prediction for acute coronary syndrome (ACS) needs better characterization.

OBJECTIVES:

This study sought to investigate the additive value of artificial intelligence-enabled quantitative coronary plaque and hemodynamic analysis (AI-QCPHA).

METHODS:

Among ACS patients who underwent coronary computed tomography angiography (CTA) from 1 month to 3 years before the ACS event, culprit and nonculprit lesions on coronary CTA were adjudicated based on invasive coronary angiography. The primary endpoint was the predictability of the risk models for ACS culprit lesions. The reference model included the Coronary Artery Disease Reporting and Data System, a standardized classification for stenosis severity, and high-risk plaque, defined as lesions with ≥2 adverse plaque characteristics. The new prediction model was the reference model plus AI-QCPHA features, selected by hierarchical clustering and information gain in the derivation cohort. The model performance was assessed in the validation cohort.

RESULTS:

Among 351 patients (age 65.9 ± 11.7 years) with 2,088 nonculprit and 363 culprit lesions, the median interval from coronary CTA to ACS event was 375 days (Q1-Q3 95-645 days), and 223 patients (63.5%) presented with myocardial infarction. In the derivation cohort (n = 243), the best AI-QCPHA features were fractional flow reserve across the lesion, plaque burden, total plaque volume, low-attenuation plaque volume, and averaged percent total myocardial blood flow. The addition of AI-QCPHA features showed higher predictability than the reference model in the validation cohort (n = 108) (AUC 0.84 vs 0.78; P < 0.001). The additive value of AI-QCPHA features was consistent across different timepoints from coronary CTA.

CONCLUSIONS:

AI-enabled plaque and hemodynamic quantification enhanced the predictability for ACS culprit lesions over the conventional coronary CTA analysis. (Exploring the Mechanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary Computed Tomography Angiography and Computational Fluid Dynamics II [EMERALD-II]; NCT03591328).
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JACC Cardiovasc Imaging Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JACC Cardiovasc Imaging Ano de publicação: 2024 Tipo de documento: Article